Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Multiple sclerosis (MS) is a chronic, autoimmune disorder of the central nervous system (CNS) that is characterized by inflammation leading to astrogliosis, demyelination and oligodendrocyte and neuronal loss.
Current treatment strategies in MS involve management of symptoms and use of disease-modifying drugs, all of which must be...
Alternative Titles
Full title
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_762481171
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762481171
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd3248